GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mochida Pharmaceutical Co Ltd (TSE:4534) » Definitions » PEG Ratio

Mochida Pharmaceutical Co (TSE:4534) PEG Ratio : N/A (As of May. 15, 2024)


View and export this data going back to 1963. Start your Free Trial

What is Mochida Pharmaceutical Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Mochida Pharmaceutical Co's PE Ratio without NRI is 25.32. Mochida Pharmaceutical Co's 5-Year EBITDA growth rate is -9.20%. Therefore, Mochida Pharmaceutical Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Mochida Pharmaceutical Co's PEG Ratio or its related term are showing as below:


During the past 13 years, Mochida Pharmaceutical Co's highest PEG Ratio was 96.24. The lowest was 1.32. And the median was 5.31.


TSE:4534's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.73
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Mochida Pharmaceutical Co PEG Ratio Historical Data

The historical data trend for Mochida Pharmaceutical Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mochida Pharmaceutical Co PEG Ratio Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 4.81 -

Mochida Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.81 10.90 11.80 - -

Competitive Comparison of Mochida Pharmaceutical Co's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mochida Pharmaceutical Co's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Mochida Pharmaceutical Co's PEG Ratio falls into.



Mochida Pharmaceutical Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Mochida Pharmaceutical Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=25.320770335744/-9.20
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Mochida Pharmaceutical Co  (TSE:4534) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Mochida Pharmaceutical Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mochida Pharmaceutical Co (TSE:4534) Business Description

Traded in Other Exchanges
N/A
Address
1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Mochida Pharmaceutical Co (TSE:4534) Headlines

No Headlines